The Medicaid Drug Utilization Review (DUR) Board met on Thursday, September 15, 2016. The final report of the meeting can be viewed here.
The Hepatitis C summary can be found on page 4. At the meeting these changes were made to Medicaid Fee-For-Service:
- Epclusa (GT 2 and 3) was added to the preferred prescription medication list.
- Viekira XR was added to the preferred prescription medication list.
An archived audio cast of the meeting proceedings is available on the Department of Health website.